Author

Jeffrey C. Jerman

Observed names: J C Jerman, J C. Jerman, J. C. JERMAN, J. C. Jerman, J. JERMAN, J. Jerman, J.C Jerman, J.C. Jerman, Jeffrey C Jerman, Jeffrey Jerman, Jerman, Jeffrey

Institution: LifeArc

Observed institutions: LifeArc, GlaxoSmithKline (United Kingdom), Molecular Discovery (United Kingdom)

OpenAlex ID: A5110000680

TRPV3 is a temperature-sensitive vanilloid receptor-like protein

2002 · G. D. Smith, M. J. Gunthorpe, et al. · Nature · 837

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

2000 · D Smart, M J Gunthorpe, et al. · British Journal of Pharmacology · 775

PDF

Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1

2002 · M Trevisani, D Smart, et al. · Nature Neuroscience · 462

SB‐334867‐A: the first selective orexin‐1 receptor antagonist

2001 · D Smart, C Sabido‐David, et al. · British Journal of Pharmacology · 308

PDF

Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist

2003 · M.J. Gunthorpe, H.K. Rami, et al. · Neuropharmacology · 274

Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell‐line using FLIPR

1999 · D Smart, J C Jerman, et al. · British Journal of Pharmacology · 189

PDF

1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor

2001 · Roderick A Porter, Wai N Chan, et al. · Bioorganic & Medicinal Chemistry Letters · 159

Characterisation of the binding of [3H]‐SB‐674042, a novel nonpeptide antagonist, to the human orexin‐1 receptor

2004 · Christopher J Langmead, Jeffrey C Jerman, et al. · British Journal of Pharmacology · 136

PDF

Discovery of SB-705498: A potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development

2006 · Harshad K. Rami, Mervyn Thompson, et al. · Bioorganic & Medicinal Chemistry Letters · 135

Characterization using FLIPR of rat vanilloid receptor (rVR1) pharmacology

2000 · J C Jerman, S J Brough, et al. · British Journal of Pharmacology · 116

PDF

Characterization of SB-705498, a Potent and Selective Vanilloid Receptor-1 (VR1/TRPV1) Antagonist That Inhibits the Capsaicin-, Acid-, and Heat-Mediated Activation of the Receptor

2007 · Martin J. Gunthorpe, Sara Luis Hannan, et al. · Journal of Pharmacology and Experimental Therapeutics · 111

Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology

2001 · Darren Smart, Jeffrey C Jerman, et al. · European Journal of Pharmacology · 106

The physiology and pharmacology of the orexins

2002 · Darren Smart, Jeffrey C Jerman · Pharmacology & Therapeutics · 97

Orexinergic neurons and barbiturate anesthesia

2003 · T Kushikata, K Hirota, et al. · Neuroscience · 93

Pharmacological characterisation of human 5-HT2 receptor subtypes

2001 · Jeffrey C Jerman, Stephen J Brough, et al. · European Journal of Pharmacology · 84

Structure–activity analysis of truncated orexin-A analogues at the orexin-1 receptor

2001 · John G Darker, Roderick A Porter, et al. · Bioorganic & Medicinal Chemistry Letters · 69

Discovery of small molecule antagonists of TRPV1

2004 · Harshad K Rami, Mervyn Thompson, et al. · Bioorganic & Medicinal Chemistry Letters · 65

Cannabinoid activation of recombinant and endogenous vanilloid receptors

2001 · Vera Ralevic, David A. Kendall, et al. · European Journal of Pharmacology · 64

Functional effects of the muscarinic receptor agonist, xanomeline, at 5‐HT1 and 5‐HT2 receptors

1998 · J. Watson, S. Brough, et al. · British Journal of Pharmacology · 64

PDF

Identification of (−)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)-3,4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent

1999 · Wai N. Chan, John M. Evans, et al. · Bioorganic & Medicinal Chemistry Letters · 54

The hypocretins are weak agonists at recombinant human orexin‐1 and orexin‐2 receptors

2000 · D Smart, J C Jerman, et al. · British Journal of Pharmacology · 51

PDF

Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid

2003 · Christopher J. Fowler, Kent-Olov Jonsson, et al. · Biochemical Pharmacology · 46

Design and synthesis of 6-phenylnicotinamide derivatives as antagonists of TRPV1

2008 · Susan M. Westaway, Mervyn Thompson, et al. · Bioorganic & Medicinal Chemistry Letters · 43

Terbinafine is a novel and selective activator of the two-pore domain potassium channel TASK3

2017 · Paul D. Wright, Emma L. Veale, et al. · Biochemical and Biophysical Research Communications · 38

PDF

Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors

2002 · J.C. Jerman, J. Gray, et al. · British Journal of Anaesthesia · 38

Works count: 53

Citation count: 4,633

H-index: 27

I10-index: 33